STOCK TITAN

[Form 4] Alamar Biosciences, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Alamar Biosciences President Timothy Ogden White reported equity awards and restructuring of his holdings in connection with the company’s initial public offering. On April 20, 2026, he received 37,220 shares of Common Stock as restricted stock units that vest monthly, bringing his direct Common Stock holdings to 491,803 shares.

The filing also shows multiple Class B Common Stock and related stock options being reclassified into equivalent Common Stock immediately prior to completion of the IPO, with no cash changing hands. Separately, on April 16, 2026, he was granted a stock option for 163,358 shares of Common Stock at an exercise price of $17.00 per share, vesting over time beginning in 2027.

Positive

  • None.

Negative

  • None.
Insider White Timothy Ogden
Role President
Type Security Shares Price Value
Other Stock Option (Right to Buy) 29,357 $0.00 --
Other Stock Option (Right to Buy) 29,357 $0.00 --
Other Stock Option (Right to Buy) 8,726 $0.00 --
Other Stock Option (Right to Buy) 8,726 $0.00 --
Other Stock Option (Right to Buy) 10,686 $0.00 --
Other Stock Option (Right to Buy) 10,686 $0.00 --
Other Stock Option (Right to Buy) 206,782 $0.00 --
Other Stock Option (Right to Buy) 206,782 $0.00 --
Other Stock Option (Right to Buy) 8,532 $0.00 --
Other Stock Option (Right to Buy) 8,532 $0.00 --
Other Stock Option (Right to Buy) 5,775 $0.00 --
Other Stock Option (Right to Buy) 5,775 $0.00 --
Other Stock Option (Right to Buy) 16,333 $0.00 --
Other Stock Option (Right to Buy) 16,333 $0.00 --
Other Class B Common Stock 454,583 $0.00 --
Other Common Stock 454,583 $0.00 --
Grant/Award Common Stock 37,220 $0.00 --
Grant/Award Stock Option (Right to Buy) 163,358 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 0 shares (Direct, null); Class B Common Stock — 0 shares (Direct, null); Common Stock — 454,583 shares (Direct, null)
Footnotes (1)
  1. Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. Represents the grant of restricted stock units ("RSUs"). The RSUs vest monthly from the date of grant, subject to the reporting person's continuous service as of each such vesting date. Twenty-five percent of the shares subject to the option vest on April 16, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date. Fully vested. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2024, subject to the reporting person's continuous service as of each such vesting date. The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date. Twenty-five percent of the shares subject to the option vest on January 1, 2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date.
RSU grant 37,220 shares Restricted stock units of Common Stock granted April 20, 2026
Common Stock holdings 491,803 shares Total Common Stock directly held after April 20, 2026 grant
New option grant 163,358 shares at $17.00 Stock option granted April 16, 2026, exercise price $17.00/share
Restructuring shares 1,481,548 shares Shares involved in J-code restructuring transactions
Option strike price $7.60 Stock option (right to buy) with $7.60 exercise price, expiring 2036-01-14
Option strike price $3.10 Stock option (right to buy) with $3.10 exercise price, expiring 2035-04-08
Option strike price $3.34 Stock options with $3.34 exercise price, various expirations
Option strike price $0.59 Stock option (right to buy) at $0.59, expiring 2031-04-20
restricted stock units ("RSUs") financial
"Represents the grant of restricted stock units ("RSUs"). The RSUs vest monthly"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Class B Common Stock financial
"Each share of Class B Common Stock was reclassified into one share of Common Stock"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
initial public offering financial
"immediately prior to the completion of the initial public offering of the Issuer's Common Stock"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
vesting financial
"The RSUs vest monthly from the date of grant, subject to the reporting person's continuous service"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
reclassified financial
"was reclassified into one share of Common Stock immediately prior to the completion"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
White Timothy Ogden

(Last)(First)(Middle)
C/O ALAMAR BIOSCIENCES, INC.
47071 BAYSIDE PARKWAY

(Street)
FREMONT CALIFORNIA 94538

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Alamar Biosciences, Inc. [ ALMR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class B Common Stock04/20/2026J(1)454,583D(1)0D
Common Stock04/20/2026J(1)454,583A(1)454,583D
Common Stock04/20/2026A(2)37,220A$0491,803D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$1704/16/2026A163,358 (3)04/15/2036Common Stock163,358$0163,358D
Stock Option (Right to Buy)$0.5904/20/2026J(1)29,357 (4)04/20/2031Class B Common Stock29,357$00D
Stock Option (Right to Buy)$0.5904/20/2026J(1)29,357 (4)04/20/2031Common Stock29,357$029,357D
Stock Option (Right to Buy)$2.2804/20/2026J(1)8,726 (4)02/15/2032Class B Common Stock8,726$00D
Stock Option (Right to Buy)$2.2804/20/2026J(1)8,726 (4)02/15/2032Common Stock8,726$08,726D
Stock Option (Right to Buy)$3.3404/20/2026J(1)10,686 (5)04/16/2034Class B Common Stock10,686$00D
Stock Option (Right to Buy)$3.3404/20/2026J(1)10,686 (5)04/16/2034Common Stock10,686$010,686D
Stock Option (Right to Buy)$3.3404/20/2026J(1)206,782 (6)01/15/2035Class B Common Stock206,782$00D
Stock Option (Right to Buy)$3.3404/20/2026J(1)206,782 (6)01/15/2035Common Stock206,782$0206,782D
Stock Option (Right to Buy)$3.3404/20/2026J(1)8,532 (7)01/15/2035Class B Common Stock8,532$00D
Stock Option (Right to Buy)$3.3404/20/2026J(1)8,532 (7)01/15/2035Common Stock8,532$08,532D
Stock Option (Right to Buy)$3.104/20/2026J(1)5,775 (8)04/08/2035Class B Common Stock5,775$00D
Stock Option (Right to Buy)$3.104/20/2026J(1)5,775 (8)04/08/2035Common Stock5,775$05,775D
Stock Option (Right to Buy)$7.604/20/2026J(1)16,333 (9)01/14/2036Class B Common Stock16,333$00D
Stock Option (Right to Buy)$7.604/20/2026J(1)16,333 (9)01/14/2036Common Stock16,333$016,333D
Explanation of Responses:
1. Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock.
2. Represents the grant of restricted stock units ("RSUs"). The RSUs vest monthly from the date of grant, subject to the reporting person's continuous service as of each such vesting date.
3. Twenty-five percent of the shares subject to the option vest on April 16, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date.
4. Fully vested.
5. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2024, subject to the reporting person's continuous service as of each such vesting date.
6. The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date.
7. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date.
8. Twenty-five percent of the shares subject to the option vest on January 1, 2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date.
9. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date.
/s/ Timothy White04/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)